118 related articles for article (PubMed ID: 10430756)
21. Intracoronary ultrasound assessment of morphological and functional abnormalities associated with cardiac allograft vasculopathy.
Heroux AL; Silverman P; Costanzo MR; O'Sullivan EJ; Johnson MR; Liao Y; McKiernan TL; Balhan JE; Leya FS; Mullen GM
Circulation; 1994 Jan; 89(1):272-7. PubMed ID: 8281657
[TBL] [Abstract][Full Text] [Related]
22. [Initial experiences with dobutamine stress echocardiography in heart transplant patients].
Günther F; Schwammenthal E; Rahmel A; Lamp B; Kerber S; Deng M; Scheld HH; Breithardt G
Z Kardiol; 1995 May; 84(5):411-8. PubMed ID: 7625105
[TBL] [Abstract][Full Text] [Related]
23. Role of intracoronary ultrasound for the diagnosis of cardiac allograft vasculopathy.
Miller LW
Transplant Proc; 1995 Jun; 27(3):1989-92. PubMed ID: 7792861
[No Abstract] [Full Text] [Related]
24. Echocardiography in the cardiac transplant recipient.
Thorn EM; de Filippi CR
Heart Fail Clin; 2007 Jan; 3(1):51-67. PubMed ID: 17545009
[TBL] [Abstract][Full Text] [Related]
25. [Value of dobutamine echocardiography in the detection of coronary disease in heart transplant patient. Groupe de Recherche VACOMED].
Derumeaux G; Redonnet M; Mouton-Schleifer D; Cribier A; Soyer R; Letac B
Arch Mal Coeur Vaiss; 1996 Jun; 89(6):687-94. PubMed ID: 8760653
[TBL] [Abstract][Full Text] [Related]
26. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
Soleimani B; Fu F; Lake P; Shi VC
J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
[TBL] [Abstract][Full Text] [Related]
27. Reliable noninvasive diagnosis of coronary allograft vasculopathy: is it still wishful thinking?
Mishra PK
Eur J Cardiothorac Surg; 2006 May; 29(5):862-3; author reply 863-4. PubMed ID: 16520039
[No Abstract] [Full Text] [Related]
28. Transmyocardial revascularization for cardiac transplantation allograft vasculopathy.
McFadden PM; Robbins RJ; Ochsner JL; Van Meter CH; Majorie S
J Thorac Cardiovasc Surg; 1998 Jun; 115(6):1385-8. PubMed ID: 9628685
[No Abstract] [Full Text] [Related]
29. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.
Kobashigawa JA; Moriguchi JD; Laks H; Wener L; Hage A; Hamilton MA; Cogert G; Marquez A; Vassilakis ME; Patel J; Yeatman L
J Heart Lung Transplant; 2005 Nov; 24(11):1736-40. PubMed ID: 16297773
[TBL] [Abstract][Full Text] [Related]
30. Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization.
Ichibori Y; Ohtani T; Nakatani D; Tachibana K; Yamaguchi O; Toda K; Akasaka T; Fukushima N; Sawa Y; Komuro I; Kotani J; Sakata Y
Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):51-8. PubMed ID: 25976347
[TBL] [Abstract][Full Text] [Related]
31. Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation.
Redonnet M; Tron C; Koning R; Bouchart F; Cribier A; Soyer R; Bessou JP
Transplant Proc; 2000 Mar; 32(2):463-5. PubMed ID: 10715480
[No Abstract] [Full Text] [Related]
32. [Doppler echocardiography after heart transplantation].
Ciliberto GR
Ital Heart J Suppl; 2000 Nov; 1(11):1411-6. PubMed ID: 11109189
[TBL] [Abstract][Full Text] [Related]
33. Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation.
Ciliberto GR; Ruffini L; Mangiavacchi M; Parolini M; Sara R; Massa D; De Maria R; Gronda E; Vitali E; Parodi O
Eur Heart J; 2001 Jun; 22(11):964-71. PubMed ID: 11428820
[TBL] [Abstract][Full Text] [Related]
34. Assessing the physiologic significance of coronary artery disease: role of Doppler methodology.
Schlaifer JD; Hill JA
Clin Cardiol; 1996 Mar; 19(3):172-8. PubMed ID: 8674251
[TBL] [Abstract][Full Text] [Related]
35. Follow-up of heart transplant recipients with serial echocardiographic coronary flow reserve and dobutamine stress echocardiography to detect cardiac allograft vasculopathy.
Sade LE; Eroğlu S; Yüce D; Bircan A; Pirat B; Sezgin A; Aydınalp A; Müderrisoğlu H
J Am Soc Echocardiogr; 2014 May; 27(5):531-9. PubMed ID: 24613313
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for the development of coronary artery disease of a grafted heart as detected very early after orthotopic heart transplantation.
Kocík M; Málek I; Janek B; Zelízko M; Pirk J
Transpl Int; 2007 Aug; 20(8):666-74. PubMed ID: 17521382
[TBL] [Abstract][Full Text] [Related]
37. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
Kittleson MM; Bead V; Fradley M; St John ME; Champion HC; Kasper EK; Russell SD; Wittstein IS; Hare JM
J Heart Lung Transplant; 2007 May; 26(5):498-503. PubMed ID: 17449420
[TBL] [Abstract][Full Text] [Related]
38. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
[TBL] [Abstract][Full Text] [Related]
39. Post-transplant surveillance for acute rejection and allograft vasculopathy by echocardiography: Usefulness of myocardial velocity and deformation imaging.
Dandel M; Hetzer R
J Heart Lung Transplant; 2017 Feb; 36(2):117-131. PubMed ID: 27876281
[TBL] [Abstract][Full Text] [Related]
40. Routine coronary angiography after heart transplantation.
Grant SC; Brooks NH; Levy RD
Heart; 1997 Aug; 78(2):101-2. PubMed ID: 9326975
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
